# Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery

> **NCT01553539** · PHASE2 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 20 (actual)

## Conditions studied

- Bone Cancer
- Chondrosarcoma
- Clear Cell Sarcoma of the Kidney
- Metastatic Osteosarcoma
- Ovarian Sarcoma
- Recurrent Adult Soft Tissue Sarcoma
- Recurrent Osteosarcoma
- Recurrent Uterine Sarcoma
- Stage III Adult Soft Tissue Sarcoma
- Stage III Uterine Sarcoma
- Stage IV Adult Soft Tissue Sarcoma
- Stage IV Uterine Sarcoma

## Interventions

- **DRUG:** therapeutic angiotensin-(1-7)
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01553539
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01553539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01553539, "Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT01553539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*